DK302887D0 - Fremstilling af laegemidler til behandling af infektionssygdomme - Google Patents

Fremstilling af laegemidler til behandling af infektionssygdomme

Info

Publication number
DK302887D0
DK302887D0 DK302887A DK302887A DK302887D0 DK 302887 D0 DK302887 D0 DK 302887D0 DK 302887 A DK302887 A DK 302887A DK 302887 A DK302887 A DK 302887A DK 302887 D0 DK302887 D0 DK 302887D0
Authority
DK
Denmark
Prior art keywords
medicinals
preparation
infectious diseases
treating infectious
treating
Prior art date
Application number
DK302887A
Other languages
English (en)
Other versions
DK302887A (da
Inventor
Michael Angelo Palladino
Arthur J Ammann
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK302887D0 publication Critical patent/DK302887D0/da
Publication of DK302887A publication Critical patent/DK302887A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK302887A 1986-06-16 1987-06-15 Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel DK302887A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87473686A 1986-06-16 1986-06-16
US5393887A 1987-05-22 1987-05-22

Publications (2)

Publication Number Publication Date
DK302887D0 true DK302887D0 (da) 1987-06-15
DK302887A DK302887A (da) 1987-12-17

Family

ID=26732412

Family Applications (1)

Application Number Title Priority Date Filing Date
DK302887A DK302887A (da) 1986-06-16 1987-06-15 Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel

Country Status (8)

Country Link
EP (1) EP0250192A3 (da)
JP (1) JPH07100662B2 (da)
AU (1) AU598817B2 (da)
DK (1) DK302887A (da)
IL (1) IL82862A0 (da)
NZ (1) NZ220686A (da)
PH (1) PH26613A (da)
PT (1) PT85076B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219027A (en) * 1986-01-24 1989-09-27 Genentech Inc Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin
DE3613166A1 (de) * 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
US5322699A (en) * 1991-02-04 1994-06-21 The Rockefeller University Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3472793D1 (en) * 1983-12-26 1988-08-25 Asahi Chemical Ind A novel physiologically active polypeptide
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor
GR851626B (da) * 1984-07-05 1985-11-26 Genentech Inc
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines

Also Published As

Publication number Publication date
JPS6354327A (ja) 1988-03-08
AU7422387A (en) 1987-12-17
EP0250192A3 (en) 1988-02-10
IL82862A0 (en) 1987-12-20
JPH07100662B2 (ja) 1995-11-01
NZ220686A (en) 1990-02-26
PT85076B (pt) 1990-07-31
EP0250192A2 (en) 1987-12-23
DK302887A (da) 1987-12-17
AU598817B2 (en) 1990-07-05
PT85076A (en) 1987-07-01
PH26613A (en) 1992-08-19

Similar Documents

Publication Publication Date Title
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DK180790D0 (da) Fremstilling af farmaceutisk praeparat
DK156688A (da) Praeparat til behandling af virusinfektioner
DK0434278T3 (da) Behandling af fugle
DK0420007T3 (da) Fremgangsmåde til rensning af human serumalbumin
PT88684A (pt) Metodo de tratamento fosfatidilico de doencas virais
DK674287A (da) Fremgangsmaade til fremstilling af optisk aktive dihydropyridinderivater
BR8701786A (pt) Preparacao de halogenetos de arila
DK298187D0 (da) Applikator til behandling af laeber
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK0439687T3 (da) Fremgangsmåde til fremstilling af alkan- og arensulfonamider
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
DK484186A (da) Fremgangsmaade til fremstilling af et praeparat til behandling af psoriasis
DK441987D0 (da) Farmaceutisk praeparat til behandling af cerebral ischaemi
DK184687A (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK117487D0 (da) Fremgangsmaade til fremstilling af inulase
DK533287A (da) Fremgangsmaade til fremstilling af azetidinoner
IT1231426B (it) Preparazione di polifluoroenolati
DK60287D0 (da) Fremgangsmaade til fremstilling af 4-acetyl-isoquinolinon-forbindelser
DK175587D0 (da) Fremstilling af substituerede (dichlormethyl)-pyridiner
DK302887A (da) Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel
DK135387D0 (da) Fremstilling af proteiner
DK234687D0 (da) Fremgangsmaade til fremstilling af ribitylxylidin
RO94667A2 (ro) Procedeu pentru prepararea azobisciclohexancarbonitrioului
DK639088A (da) Laegemiddel til behandling af iskaemiske hjertesygdomme

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment